Predicting Conversion from Subjective Cognitive Decline to Mild Cognitive Impairment and Alzheimer's Disease Dementia Using Ensemble Machine Learning.

BACKGROUND Subjective cognitive decline (SCD) may represent a preclinical stage of Alzheimer's disease (AD). Predicting progression of SCD patients is of great importance in AD-related research but remains a challenge. OBJECTIVE To develop and implement an ensemble machine learning (ML) algorithm to identify SCD subjects at risk of conversion to mild cognitive impairment (MCI) or AD. METHODS Ninety-nine SCD patients were included. Thirty-two progressed to MCI/AD, while 67 remained stable. To minimize the effect of class imbalance, both classes were balanced, and sensitivity was taken as evaluation metric. Bagging and boosting ML models were developed by using socio-demographic and clinical information, Mini-Mental State Examination and Geriatric Depression Scale (GDS) scores (feature-set 1a); socio-demographic characteristics and neuropsychological tests scores (feature-set 1b) and regional magnetic resonance imaging grey matter volumes (feature-set 2). The most relevant variables were combined to find the best model. RESULTS Good prediction performances were obtained with feature-sets 1a and 2. The most relevant variables (variable importance exceeding 20%) were: Age, GDS, and grey matter volumes measured in four cortical regions of interests. Their combination provided the optimal classification performance (highest sensitivity and specificity) ensemble ML model, Extreme Gradient Boosting with over-sampling of the minority class, with performance metrics: sensitivity = 1.00, specificity = 0.92 and area-under-the-curve = 0.96. The median values based on fifty random train/test splits were sensitivity = 0.83 (interquartile range (IQR) = 0.17), specificity = 0.77 (IQR = 0.23) and area-under-the-curve = 0.75 (IQR = 0.11). CONCLUSION A high-performance algorithm that could be translatable into practice was able to predict SCD conversion to MCI/AD by using only six predictive variables.

[1]  M. Välimäki,et al.  A Risk Prediction Model Based on Machine Learning for Cognitive Impairment Among Chinese Community-Dwelling Elderly People With Normal Cognition: Development and Validation Study , 2021, Journal of medical Internet research.

[2]  T. Tong,et al.  Predicting Alzheimer’s Disease Conversion From Mild Cognitive Impairment Using an Extreme Learning Machine-Based Grading Method With Multimodal Data , 2020, Frontiers in Aging Neuroscience.

[3]  Michael Wagner,et al.  The characterisation of subjective cognitive decline , 2020, The Lancet Neurology.

[4]  Yan Yan,et al.  Classification of Alzheimer’s Disease with and without Imagery Using Gradient Boosted Machines and ResNet-50 , 2019, Brain sciences.

[5]  Pei-yan Shan,et al.  Subjective cognitive decline: preclinical manifestation of Alzheimer’s disease , 2018, Neurological Sciences.

[6]  M. Politis,et al.  Magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment , 2018, Journal of Neurology.

[7]  S. Sorbi,et al.  From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study. , 2018, Journal of Alzheimer's disease : JAD.

[8]  Constantino Carlos Reyes-Aldasoro,et al.  Quantitative MRI Brain Studies in Mild Cognitive Impairment and Alzheimer's Disease: A Methodological Review , 2018, IEEE Reviews in Biomedical Engineering.

[9]  Kipp W. Johnson,et al.  Machine learning in cardiovascular medicine: are we there yet? , 2018, Heart.

[10]  Shoab Ahmad Khan,et al.  A Nonparametric Approach for Mild Cognitive Impairment to AD Conversion Prediction: Results on Longitudinal Data , 2017, IEEE Journal of Biomedical and Health Informatics.

[11]  C. Smart,et al.  Subjective Cognitive Decline in Preclinical Alzheimer's Disease. , 2017, Annual review of clinical psychology.

[12]  S. H. Hojjati,et al.  Predicting conversion from MCI to AD using resting-state fMRI, graph theoretical approach and SVM , 2017, Journal of Neuroscience Methods.

[13]  Federica Scarpina,et al.  The Stroop Color and Word Test , 2017, Front. Psychol..

[14]  Andrew J. Saykin,et al.  Implementation of subjective cognitive decline criteria in research studies , 2017, Alzheimer's & Dementia.

[15]  Ming-Jang Chiu,et al.  From mild cognitive impairment to subjective cognitive decline: conceptual and methodological evolution , 2017, Neuropsychiatric disease and treatment.

[16]  Arthur Konnerth,et al.  Impairments of neural circuit function in Alzheimer's disease , 2016, Philosophical Transactions of the Royal Society B: Biological Sciences.

[17]  Xintao Hu,et al.  Network-selective vulnerability of the human cerebellum to Alzheimer's disease and frontotemporal dementia. , 2016, Brain : a journal of neurology.

[18]  G. Busatto,et al.  Voxel-based morphometry in Alzheimers disease and mild cognitive impairment: Systematic review of studies addressing the frontal lobe , 2016, Dementia & neuropsychologia.

[19]  Koen Van Leemput,et al.  Regional Hippocampal Atrophy and Higher Levels of Plasma Amyloid-Beta Are Associated With Subjective Memory Complaints in Nondemented Elderly Subjects. , 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

[20]  D. G. Clark,et al.  Novel verbal fluency scores and structural brain imaging for prediction of cognitive outcome in mild cognitive impairment , 2016, Alzheimer's & dementia.

[21]  K. Blennow,et al.  The Gothenburg MCI study: Design and distribution of Alzheimer’s disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[22]  Fabio Sambataro,et al.  Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers. , 2015, Journal of Alzheimer's disease : JAD.

[23]  Brigitte Landeau,et al.  Hippocampal Subfield Volumetry and 3D Surface Mapping in Subjective Cognitive Decline. , 2015, Journal of Alzheimer's disease : JAD.

[24]  Frank Jessen,et al.  Subjective Cognitive Decline , 2021, Encyclopedia of Gerontology and Population Aging.

[25]  Christine Van Broeckhoven,et al.  The genetic landscape of Alzheimer disease: clinical implications and perspectives , 2015, Genetics in Medicine.

[26]  D. Y. Lee,et al.  Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. , 2015, JAMA.

[27]  P. Sachdev,et al.  Hippocampal atrophy is associated with subjective memory decline: The PATH Through Life study. , 2015, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[28]  C. Lyketsos,et al.  Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis. , 2015, The American journal of psychiatry.

[29]  Heikki Huttunen,et al.  Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects , 2015, NeuroImage.

[30]  B. Winblad,et al.  Subjective Cognitive Impairment Subjects in Our Clinical Practice , 2014, Dementia and Geriatric Cognitive Disorders Extra.

[31]  Andrew J. Saykin,et al.  A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease , 2014, Alzheimer's & Dementia.

[32]  Sejong Bae,et al.  A Study of Effects of MultiCollinearity in the Multivariable Analysis. , 2014, International journal of applied science and technology.

[33]  J. Breitner Mild cognitive impairment and progression to dementia , 2014, Neurology.

[34]  F. Jessen,et al.  AD dementia risk in late MCI, in early MCI, and in subjective memory impairment , 2014, Alzheimer's & Dementia.

[35]  O. Forlenza,et al.  Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's disease. , 2013, Revista brasileira de psiquiatria.

[36]  J. Trojanowski,et al.  Clinical utility and analytical challenges in measurement of cerebrospinal fluid amyloid-β(1-42) and τ proteins as Alzheimer disease biomarkers. , 2013, Clinical chemistry.

[37]  Joaquim Radua,et al.  Meta-analysis of functional network alterations in Alzheimer's disease: Toward a network biomarker , 2013, Neuroscience & Biobehavioral Reviews.

[38]  Keith A. Johnson,et al.  Biomarkers of Alzheimer Disease: Current and Future Applications to Diagnostic Criteria , 2013, Continuum.

[39]  Ranjan Duara,et al.  An investigation of PreMCI: Subtypes and longitudinal outcomes , 2012, Alzheimer's & Dementia.

[40]  B. Gordon,et al.  Ideational fluency as a domain of human cognition. , 2012, Neuropsychology.

[41]  Ying Han,et al.  Anatomical and Functional Deficits in Patients with Amnestic Mild Cognitive Impairment , 2012, PloS one.

[42]  W. Klunk Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia , 2011, Neurobiology of Aging.

[43]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[44]  Nick C Fox,et al.  The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[45]  Nick C Fox,et al.  The clinical use of structural MRI in Alzheimer disease , 2010, Nature Reviews Neurology.

[46]  F. Jessen,et al.  Volume Loss of the Medial Temporal Lobe Structures in Subjective Memory Impairment , 2010, Dementia and Geriatric Cognitive Disorders.

[47]  J. Molinuevo,et al.  Spanish Multicenter Normative Studies (NEURONORMA Project): norms for verbal span, visuospatial span, letter and number sequencing, trail making test, and symbol digit modalities test. , 2009, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[48]  C. Jack,et al.  Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment , 2008, Neurology.

[49]  P. Scheltens,et al.  Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria , 2007, The Lancet Neurology.

[50]  Tibor Petres,et al.  A New Measure of Multicollinearity in Linear Regression Models , 2005 .

[51]  Faiza Admiraal-Behloul,et al.  Memory complaints in patients with normal cognition are associated with smaller hippocampal volumes , 2004, Journal of Neurology.

[52]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[53]  J Peña-Casanova,et al.  Clinical Validity and Utility of the Interview for Deterioration of Daily Living in Dementia for Spanish-Speaking Communities , 1998, International Psychogeriatrics.

[54]  L. Squire,et al.  The medial temporal lobe memory system , 1991, Science.

[55]  H. Buschke,et al.  Cued recall in amnesia. , 1984, Journal of clinical neuropsychology.

[56]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[57]  Maurice G. Kendall,et al.  A course in multivariate analysis , 1958 .

[58]  Emiliano Bruner,et al.  The cerebellum in Alzheimer's disease: evaluating its role in cognitive decline. , 2018, Brain : a journal of neurology.

[59]  Michael Wagner,et al.  Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment. , 2017, Journal of Alzheimer's disease : JAD.

[60]  Shuangzhe Liu,et al.  Regression diagnostics , 2020, Applied Quantitative Analysis for Real Estate.

[61]  P. Visser,et al.  Biomarkers as predictors for conversion from mild cognitive impairment to Alzheimer-type dementia: implications for trial design. , 2010, Journal of Alzheimer's disease : JAD.

[62]  Leo Breiman,et al.  Bagging Predictors , 1996, Machine Learning.

[63]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.